Bophelo Enters into $30 Million Offtake Agreement with Medcan

TORONTO–(BUSINESS WIRE)–Bophelo Bio Science & Wellness Pty Ltd (“Bophelo”), a company registered in the Kingdom of Lesotho, and a wholly-owned subisidary of Halo Labs Inc. (“Halo”) (NEO: HALO; OTCQX: AGEEF, Germany: A9KN), has entered into an offtake agreement (the “Agreement”) with Medcan Ltd (“Medcan”), a company incorporated in the Republic of Malta, for the sale of bulk cannabis biomass, primarily into the European market. The term of the Agreement is for a period commencing on August

READ MORE: http://www.businesswire.com/news/home/20200807005498/en/%C2%A0Bophelo-Enters-30-Million-Offtake-Agreement-Medcan/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB7TDOU5CqE9t5WwBA1inzlrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVIbE9ZC1pD3bt6lQgRU5j6g==